Your 25-second video preview has ended.
to continue watching, please Log In or Register:
How Oxervate Targets Neurotrophic Keratitis
W. Barry Lee, MD, FACS, sits down with Clifford Salinger, MD, to learn about Oxervate (cenegermin) by Dompé Farmaceutici. Oxervate is FDA-approved human recombinant nerve growth factor for the treatment of neurotrophic keratitis. In this video. Dr. Salinger explains the drug's theoretical mechanism of action.